CareDx (CDNA) Competitors $18.83 -1.25 (-6.23%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDNA vs. SHC, SGRY, PRVA, CON, LFST, WGS, VCYT, ARDT, ADUS, and PGNYShould you be buying CareDx stock or one of its competitors? The main competitors of CareDx include Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), GeneDx (WGS), Veracyte (VCYT), Ardent Health Partners (ARDT), Addus HomeCare (ADUS), and Progyny (PGNY). These companies are all part of the "healthcare" industry. CareDx vs. Its Competitors Sotera Health Surgery Partners Privia Health Group Concentra Group Holdings Parent LifeStance Health Group GeneDx Veracyte Ardent Health Partners Addus HomeCare Progyny Sotera Health (NASDAQ:SHC) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends. Which has stronger valuation & earnings, SHC or CDNA? Sotera Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSotera Health$1.11B3.01$51.38M$0.08146.88CareDx$346.42M3.03-$190.28M$1.1516.37 Do institutionals and insiders believe in SHC or CDNA? 91.0% of Sotera Health shares are owned by institutional investors. 47.5% of Sotera Health shares are owned by company insiders. Comparatively, 4.4% of CareDx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts rate SHC or CDNA? Sotera Health currently has a consensus target price of $15.80, suggesting a potential upside of 34.47%. CareDx has a consensus target price of $30.33, suggesting a potential upside of 61.09%. Given CareDx's higher probable upside, analysts plainly believe CareDx is more favorable than Sotera Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sotera Health 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80CareDx 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is SHC or CDNA more profitable? Sotera Health has a net margin of 6.31% compared to CareDx's net margin of -45.90%. Sotera Health's return on equity of 42.27% beat CareDx's return on equity.Company Net Margins Return on Equity Return on Assets Sotera Health6.31% 42.27% 6.02% CareDx -45.90%-53.70%-30.42% Does the media prefer SHC or CDNA? In the previous week, Sotera Health had 3 more articles in the media than CareDx. MarketBeat recorded 8 mentions for Sotera Health and 5 mentions for CareDx. CareDx's average media sentiment score of 1.35 beat Sotera Health's score of 0.99 indicating that CareDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CareDx 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in SHC or CDNA? CareDx received 391 more outperform votes than Sotera Health when rated by MarketBeat users. Likewise, 65.78% of users gave CareDx an outperform vote while only 58.24% of users gave Sotera Health an outperform vote. CompanyUnderperformOutperformSotera HealthOutperform Votes5358.24% Underperform Votes3841.76% CareDxOutperform Votes44465.78% Underperform Votes23134.22% Which has more volatility & risk, SHC or CDNA? Sotera Health has a beta of 1.87, indicating that its stock price is 87% more volatile than the S&P 500. Comparatively, CareDx has a beta of 2.18, indicating that its stock price is 118% more volatile than the S&P 500. SummarySotera Health beats CareDx on 10 of the 17 factors compared between the two stocks. Get CareDx News Delivered to You Automatically Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDNA vs. The Competition Export to ExcelMetricCareDxMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.05B$3.10B$5.61B$8.62BDividend YieldN/A31.25%5.28%4.18%P/E Ratio-6.9714.1527.2619.97Price / Sales3.03178.39412.06157.64Price / CashN/A57.5638.2534.64Price / Book3.904.757.064.69Net Income-$190.28M-$22.21M$3.24B$248.14M7 Day Performance0.37%4.93%2.56%2.39%1 Month Performance15.10%6.65%8.75%6.06%1 Year Performance23.15%14.92%31.30%13.57% CareDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDNACareDx3.8061 of 5 stars$18.83-6.2%$30.33+61.1%+34.9%$1.05B$346.42M-6.97740Positive NewsSHCSotera Health3.5882 of 5 stars$12.19-0.4%$15.80+29.6%-0.6%$3.46B$1.11B48.763,000Positive NewsSGRYSurgery Partners2.7987 of 5 stars$23.39-0.9%$33.56+43.5%-6.9%$3.00B$3.17B-48.7312,200PRVAPrivia Health Group3.7996 of 5 stars$22.83+0.3%$27.77+21.6%+37.5%$2.78B$1.80B228.32810CONConcentra Group Holdings ParentN/A$21.44-0.9%$28.50+32.9%N/A$2.73B$1.93B16.0011,000Positive NewsLFSTLifeStance Health Group2.6123 of 5 stars$5.88-1.0%$8.50+44.6%+6.1%$2.29B$1.28B-22.626,640WGSGeneDx3.7731 of 5 stars$74.13+4.1%$86.75+17.0%+160.1%$2.12B$330.14M-37.821,200Positive NewsVCYTVeracyte4.0069 of 5 stars$26.74+0.5%$40.90+53.0%+31.2%$2.09B$463.39M-178.27790ARDTArdent Health Partners3.309 of 5 stars$14.43-0.4%$20.67+43.3%N/A$2.06B$6.02B8.8524,200Positive NewsADUSAddus HomeCare4.7808 of 5 stars$111.20+0.3%$142.57+28.2%-4.5%$2.05B$1.21B25.4533,200Positive NewsAnalyst ForecastAnalyst RevisionPGNYProgyny0.9567 of 5 stars$21.70+0.9%$23.45+8.1%-22.8%$1.86B$1.21B37.41310 Related Companies and Tools Related Companies Sotera Health Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives LifeStance Health Group Alternatives GeneDx Alternatives Veracyte Alternatives Ardent Health Partners Alternatives Addus HomeCare Alternatives Progyny Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDNA) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareDx, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CareDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.